| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 52 | 2025 | 165 | 12.290 |
Why?
|
| Gynecologic Surgical Procedures | 48 | 2024 | 159 | 10.870 |
Why?
|
| Urinary Incontinence, Stress | 60 | 2024 | 198 | 7.810 |
Why?
|
| Urinary Incontinence | 45 | 2024 | 216 | 7.640 |
Why?
|
| Suburethral Slings | 26 | 2024 | 77 | 5.160 |
Why?
|
| Gynecology | 20 | 2023 | 129 | 5.130 |
Why?
|
| Obstetrics | 15 | 2022 | 123 | 4.680 |
Why?
|
| Uterine Prolapse | 38 | 2024 | 82 | 4.500 |
Why?
|
| Hysterectomy | 27 | 2024 | 161 | 4.130 |
Why?
|
| Urethra | 23 | 2025 | 114 | 4.120 |
Why?
|
| Pelvic Floor | 26 | 2025 | 86 | 4.020 |
Why?
|
| Urologic Surgical Procedures | 22 | 2021 | 150 | 3.970 |
Why?
|
| Urinary Bladder | 31 | 2025 | 250 | 3.730 |
Why?
|
| Pelvic Floor Disorders | 14 | 2024 | 56 | 3.670 |
Why?
|
| Female | 260 | 2025 | 47901 | 3.070 |
Why?
|
| Vagina | 23 | 2024 | 176 | 2.990 |
Why?
|
| Laparoscopy | 21 | 2024 | 767 | 2.850 |
Why?
|
| Urinary Bladder, Overactive | 16 | 2025 | 91 | 2.710 |
Why?
|
| Urinary Incontinence, Urge | 19 | 2025 | 50 | 2.560 |
Why?
|
| Lower Urinary Tract Symptoms | 16 | 2025 | 76 | 2.450 |
Why?
|
| Patient Satisfaction | 18 | 2023 | 505 | 2.420 |
Why?
|
| Anal Canal | 12 | 2021 | 90 | 2.400 |
Why?
|
| Urodynamics | 29 | 2025 | 125 | 2.360 |
Why?
|
| Urinary Tract | 5 | 2023 | 35 | 2.330 |
Why?
|
| Robotic Surgical Procedures | 10 | 2024 | 342 | 2.270 |
Why?
|
| Middle Aged | 160 | 2025 | 27045 | 2.220 |
Why?
|
| Humans | 269 | 2025 | 92351 | 2.190 |
Why?
|
| Postoperative Complications | 40 | 2024 | 2454 | 1.910 |
Why?
|
| Fecal Incontinence | 18 | 2024 | 59 | 1.870 |
Why?
|
| Lacerations | 6 | 2021 | 29 | 1.860 |
Why?
|
| Aged | 115 | 2025 | 19952 | 1.790 |
Why?
|
| Surgical Mesh | 18 | 2024 | 124 | 1.780 |
Why?
|
| Adult | 127 | 2025 | 27547 | 1.750 |
Why?
|
| Surveys and Questionnaires | 51 | 2025 | 2730 | 1.640 |
Why?
|
| Internship and Residency | 13 | 2023 | 1086 | 1.540 |
Why?
|
| Quality of Life | 36 | 2023 | 1745 | 1.400 |
Why?
|
| Ureter | 3 | 2020 | 96 | 1.330 |
Why?
|
| Reoperation | 6 | 2022 | 653 | 1.330 |
Why?
|
| Treatment Outcome | 53 | 2025 | 8730 | 1.300 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2024 | 617 | 1.250 |
Why?
|
| Minimally Invasive Surgical Procedures | 7 | 2024 | 275 | 1.250 |
Why?
|
| Postoperative Care | 3 | 2021 | 238 | 1.230 |
Why?
|
| Prospective Studies | 37 | 2025 | 4474 | 1.220 |
Why?
|
| Surgeons | 3 | 2022 | 263 | 1.210 |
Why?
|
| Obstetric Labor Complications | 4 | 2021 | 34 | 1.180 |
Why?
|
| Leadership | 2 | 2022 | 147 | 1.170 |
Why?
|
| Retrospective Studies | 46 | 2025 | 9694 | 1.140 |
Why?
|
| Robotics | 4 | 2014 | 268 | 1.100 |
Why?
|
| Dyspareunia | 3 | 2023 | 22 | 1.080 |
Why?
|
| Educational Measurement | 3 | 2018 | 235 | 1.070 |
Why?
|
| Clinical Competence | 6 | 2022 | 809 | 1.050 |
Why?
|
| Sexism | 4 | 2023 | 57 | 1.030 |
Why?
|
| Microbiota | 3 | 2022 | 412 | 1.020 |
Why?
|
| Urination Disorders | 9 | 2025 | 54 | 0.990 |
Why?
|
| Cystoscopy | 3 | 2020 | 37 | 0.960 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2021 | 51 | 0.930 |
Why?
|
| Cross-Sectional Studies | 19 | 2024 | 1773 | 0.930 |
Why?
|
| Hysteroscopy | 2 | 2015 | 6 | 0.910 |
Why?
|
| Defecation | 5 | 2013 | 25 | 0.910 |
Why?
|
| Pessaries | 7 | 2025 | 11 | 0.910 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2015 | 38 | 0.900 |
Why?
|
| Extraction, Obstetrical | 2 | 2021 | 7 | 0.900 |
Why?
|
| Sensory Thresholds | 4 | 2012 | 57 | 0.870 |
Why?
|
| Neurons, Afferent | 4 | 2008 | 78 | 0.870 |
Why?
|
| Quality Improvement | 5 | 2022 | 474 | 0.860 |
Why?
|
| Hospitals, Religious | 3 | 2019 | 30 | 0.820 |
Why?
|
| Obstetric Surgical Procedures | 2 | 2017 | 10 | 0.820 |
Why?
|
| Family Planning Services | 3 | 2019 | 43 | 0.820 |
Why?
|
| Curriculum | 6 | 2020 | 584 | 0.800 |
Why?
|
| Pressure | 6 | 2025 | 169 | 0.800 |
Why?
|
| Uterine Neoplasms | 2 | 2021 | 256 | 0.800 |
Why?
|
| Abdomen | 4 | 2020 | 125 | 0.790 |
Why?
|
| Intraoperative Complications | 6 | 2020 | 189 | 0.780 |
Why?
|
| Referral and Consultation | 4 | 2021 | 353 | 0.770 |
Why?
|
| Clinical Decision-Making | 2 | 2024 | 290 | 0.770 |
Why?
|
| United States | 26 | 2024 | 7367 | 0.760 |
Why?
|
| Pelvic Pain | 4 | 2024 | 86 | 0.760 |
Why?
|
| Electric Stimulation Therapy | 2 | 2020 | 49 | 0.760 |
Why?
|
| Behavior Therapy | 6 | 2013 | 93 | 0.750 |
Why?
|
| Pregnancy | 21 | 2024 | 3113 | 0.750 |
Why?
|
| Supine Position | 2 | 2020 | 32 | 0.750 |
Why?
|
| Personnel Selection | 2 | 2023 | 62 | 0.740 |
Why?
|
| Correspondence as Topic | 1 | 2021 | 4 | 0.740 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 130 | 0.710 |
Why?
|
| Neuromuscular Junction | 3 | 2015 | 78 | 0.710 |
Why?
|
| Uterus | 4 | 2012 | 222 | 0.710 |
Why?
|
| Convalescence | 1 | 2021 | 12 | 0.700 |
Why?
|
| Early Detection of Cancer | 3 | 2014 | 470 | 0.690 |
Why?
|
| Aged, 80 and over | 41 | 2025 | 6918 | 0.690 |
Why?
|
| Neuromuscular Agents | 1 | 2021 | 28 | 0.680 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 306 | 0.680 |
Why?
|
| Watchful Waiting | 1 | 2021 | 69 | 0.670 |
Why?
|
| Patient Participation | 2 | 2021 | 227 | 0.650 |
Why?
|
| Hematuria | 2 | 2017 | 50 | 0.650 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 105 | 0.650 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 64 | 0.650 |
Why?
|
| Intermittent Urethral Catheterization | 1 | 2019 | 5 | 0.640 |
Why?
|
| Cesarean Section | 4 | 2020 | 148 | 0.640 |
Why?
|
| Sex Characteristics | 1 | 2022 | 331 | 0.640 |
Why?
|
| Racism | 1 | 2021 | 96 | 0.630 |
Why?
|
| Patient Positioning | 1 | 2020 | 63 | 0.630 |
Why?
|
| Cystitis, Interstitial | 3 | 2017 | 54 | 0.630 |
Why?
|
| Urologic Diseases | 1 | 2019 | 42 | 0.620 |
Why?
|
| Endometrial Neoplasms | 2 | 2012 | 212 | 0.620 |
Why?
|
| Electromyography | 9 | 2021 | 191 | 0.620 |
Why?
|
| Religion and Medicine | 2 | 2011 | 121 | 0.620 |
Why?
|
| Severity of Illness Index | 25 | 2019 | 1920 | 0.610 |
Why?
|
| Patient Compliance | 4 | 2014 | 236 | 0.610 |
Why?
|
| Self Care | 2 | 2019 | 169 | 0.600 |
Why?
|
| Muscarinic Antagonists | 6 | 2011 | 59 | 0.600 |
Why?
|
| Phenylpropanolamine | 5 | 2011 | 15 | 0.600 |
Why?
|
| Cresols | 5 | 2011 | 17 | 0.600 |
Why?
|
| Suture Techniques | 6 | 2024 | 142 | 0.590 |
Why?
|
| Hysterectomy, Vaginal | 6 | 2022 | 15 | 0.590 |
Why?
|
| Benzhydryl Compounds | 5 | 2011 | 44 | 0.580 |
Why?
|
| Postoperative Period | 8 | 2024 | 311 | 0.570 |
Why?
|
| Cohort Studies | 15 | 2024 | 2979 | 0.570 |
Why?
|
| Workplace | 1 | 2018 | 30 | 0.570 |
Why?
|
| Staff Development | 1 | 2018 | 29 | 0.560 |
Why?
|
| Postpartum Period | 9 | 2023 | 159 | 0.560 |
Why?
|
| Goals | 7 | 2021 | 67 | 0.560 |
Why?
|
| Exercise | 1 | 2021 | 335 | 0.550 |
Why?
|
| Feedback | 1 | 2018 | 137 | 0.540 |
Why?
|
| Lactobacillus acidophilus | 1 | 2017 | 7 | 0.540 |
Why?
|
| Parturition | 3 | 2023 | 23 | 0.530 |
Why?
|
| Chemokine CCL22 | 1 | 2017 | 8 | 0.530 |
Why?
|
| Leiomyoma | 1 | 2021 | 206 | 0.530 |
Why?
|
| Directive Counseling | 1 | 2017 | 35 | 0.520 |
Why?
|
| Patient Handoff | 1 | 2018 | 95 | 0.510 |
Why?
|
| Interleukin-4 | 1 | 2017 | 131 | 0.510 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 104 | 0.510 |
Why?
|
| Reproducibility of Results | 17 | 2022 | 2793 | 0.510 |
Why?
|
| Young Adult | 21 | 2024 | 6629 | 0.490 |
Why?
|
| Delivery, Obstetric | 9 | 2021 | 120 | 0.490 |
Why?
|
| Faculty, Medical | 1 | 2018 | 198 | 0.490 |
Why?
|
| Operative Time | 5 | 2024 | 156 | 0.480 |
Why?
|
| Logistic Models | 12 | 2025 | 1239 | 0.470 |
Why?
|
| Rectocele | 2 | 2014 | 7 | 0.470 |
Why?
|
| Pain Measurement | 7 | 2021 | 360 | 0.460 |
Why?
|
| Man-Machine Systems | 1 | 2014 | 10 | 0.460 |
Why?
|
| Time Factors | 20 | 2024 | 5431 | 0.460 |
Why?
|
| Time-to-Treatment | 3 | 2021 | 129 | 0.460 |
Why?
|
| Musculoskeletal Pain | 1 | 2014 | 10 | 0.450 |
Why?
|
| Nocturia | 5 | 2025 | 22 | 0.450 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2014 | 34 | 0.440 |
Why?
|
| Occupational Diseases | 1 | 2014 | 55 | 0.430 |
Why?
|
| Electronic Health Records | 3 | 2023 | 364 | 0.430 |
Why?
|
| Education, Medical, Graduate | 4 | 2020 | 413 | 0.420 |
Why?
|
| Urogenital Surgical Procedures | 3 | 2007 | 10 | 0.420 |
Why?
|
| Education, Medical | 2 | 2014 | 246 | 0.420 |
Why?
|
| Case-Control Studies | 10 | 2025 | 1900 | 0.420 |
Why?
|
| Peripartum Period | 1 | 2013 | 29 | 0.410 |
Why?
|
| Vaginal Birth after Cesarean | 3 | 2021 | 7 | 0.410 |
Why?
|
| Pain | 8 | 2023 | 406 | 0.400 |
Why?
|
| Follow-Up Studies | 13 | 2024 | 3775 | 0.400 |
Why?
|
| Male | 21 | 2025 | 43928 | 0.400 |
Why?
|
| Biomedical Research | 4 | 2024 | 407 | 0.400 |
Why?
|
| Medical Records | 4 | 2008 | 122 | 0.400 |
Why?
|
| Women's Health | 4 | 2024 | 105 | 0.390 |
Why?
|
| Sutures | 5 | 2024 | 59 | 0.390 |
Why?
|
| Preoperative Period | 4 | 2020 | 98 | 0.390 |
Why?
|
| Risk Factors | 20 | 2024 | 5708 | 0.390 |
Why?
|
| Gastrointestinal Transit | 1 | 2012 | 19 | 0.380 |
Why?
|
| Double-Blind Method | 4 | 2021 | 1755 | 0.380 |
Why?
|
| Constipation | 4 | 2018 | 69 | 0.380 |
Why?
|
| Guideline Adherence | 2 | 2014 | 239 | 0.380 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 274 | 0.380 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 255 | 0.370 |
Why?
|
| Public Health | 2 | 2023 | 146 | 0.370 |
Why?
|
| Mental Recall | 3 | 2013 | 166 | 0.370 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 232 | 0.360 |
Why?
|
| Operating Rooms | 2 | 2018 | 134 | 0.360 |
Why?
|
| Muscles | 1 | 2011 | 190 | 0.350 |
Why?
|
| Muscle Contraction | 6 | 2025 | 287 | 0.350 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2011 | 22 | 0.350 |
Why?
|
| Needs Assessment | 3 | 2020 | 159 | 0.350 |
Why?
|
| Sexual Behavior | 4 | 2018 | 320 | 0.340 |
Why?
|
| Electrophysiology | 2 | 2008 | 402 | 0.340 |
Why?
|
| Contraceptive Agents, Female | 1 | 2011 | 30 | 0.340 |
Why?
|
| Pilot Projects | 7 | 2021 | 902 | 0.330 |
Why?
|
| Urination | 1 | 2010 | 40 | 0.330 |
Why?
|
| Personality | 1 | 2011 | 139 | 0.330 |
Why?
|
| Pelvis | 5 | 2021 | 97 | 0.330 |
Why?
|
| Proprioception | 1 | 2010 | 32 | 0.320 |
Why?
|
| Contraception | 1 | 2011 | 99 | 0.320 |
Why?
|
| Sexual Dysfunction, Physiological | 4 | 2018 | 73 | 0.320 |
Why?
|
| Prevalence | 12 | 2025 | 1298 | 0.320 |
Why?
|
| Abortion, Induced | 2 | 2019 | 149 | 0.320 |
Why?
|
| Sensation | 4 | 2025 | 50 | 0.320 |
Why?
|
| Informed Consent | 2 | 2013 | 278 | 0.310 |
Why?
|
| Urine | 3 | 2017 | 93 | 0.310 |
Why?
|
| Diagnostic Techniques, Urological | 5 | 2013 | 13 | 0.310 |
Why?
|
| General Surgery | 2 | 2015 | 238 | 0.310 |
Why?
|
| Health Status Indicators | 5 | 2019 | 103 | 0.310 |
Why?
|
| Sleep Wake Disorders | 2 | 2022 | 121 | 0.310 |
Why?
|
| Exercise Therapy | 4 | 2024 | 88 | 0.300 |
Why?
|
| Adolescent | 14 | 2024 | 9495 | 0.300 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2011 | 183 | 0.290 |
Why?
|
| Thermosensing | 1 | 2008 | 4 | 0.290 |
Why?
|
| Multivariate Analysis | 7 | 2020 | 995 | 0.290 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2008 | 4 | 0.290 |
Why?
|
| Health Services Accessibility | 2 | 2017 | 452 | 0.290 |
Why?
|
| Teaching | 2 | 2006 | 147 | 0.290 |
Why?
|
| Length of Stay | 4 | 2024 | 790 | 0.290 |
Why?
|
| Prosthesis Implantation | 3 | 2016 | 130 | 0.290 |
Why?
|
| Botulinum Toxins | 1 | 2008 | 17 | 0.290 |
Why?
|
| Databases, Factual | 3 | 2020 | 955 | 0.280 |
Why?
|
| Needles | 2 | 2024 | 41 | 0.280 |
Why?
|
| Neurologic Examination | 1 | 2008 | 124 | 0.280 |
Why?
|
| Urinary Retention | 6 | 2024 | 43 | 0.280 |
Why?
|
| Pain Threshold | 2 | 2009 | 61 | 0.270 |
Why?
|
| Patient Selection | 4 | 2024 | 689 | 0.270 |
Why?
|
| Narcotics | 2 | 2021 | 71 | 0.260 |
Why?
|
| Recovery of Function | 6 | 2021 | 318 | 0.260 |
Why?
|
| Urinary Tract Infections | 3 | 2019 | 80 | 0.260 |
Why?
|
| Equipment Design | 4 | 2024 | 420 | 0.260 |
Why?
|
| Touch | 1 | 2008 | 105 | 0.260 |
Why?
|
| Sex Factors | 4 | 2025 | 1094 | 0.260 |
Why?
|
| Aging | 3 | 2011 | 742 | 0.260 |
Why?
|
| Anatomy | 1 | 2006 | 21 | 0.260 |
Why?
|
| Obesity | 4 | 2024 | 1014 | 0.260 |
Why?
|
| Research | 1 | 2007 | 254 | 0.250 |
Why?
|
| Combined Modality Therapy | 5 | 2021 | 1733 | 0.250 |
Why?
|
| Foreign-Body Migration | 2 | 2005 | 34 | 0.250 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2022 | 259 | 0.250 |
Why?
|
| Sexual Dysfunctions, Psychological | 3 | 2018 | 36 | 0.240 |
Why?
|
| Education | 2 | 2020 | 58 | 0.230 |
Why?
|
| Urology | 5 | 2020 | 125 | 0.230 |
Why?
|
| Polypropylenes | 3 | 2023 | 23 | 0.230 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1191 | 0.230 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 399 | 0.230 |
Why?
|
| Linear Models | 5 | 2021 | 427 | 0.230 |
Why?
|
| Sacrum | 5 | 2024 | 59 | 0.220 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 369 | 0.220 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 69 | 0.210 |
Why?
|
| Research Design | 4 | 2024 | 600 | 0.210 |
Why?
|
| Electric Stimulation | 4 | 2021 | 371 | 0.210 |
Why?
|
| Age Factors | 6 | 2025 | 1904 | 0.210 |
Why?
|
| Depression, Postpartum | 1 | 2024 | 16 | 0.210 |
Why?
|
| Poland | 2 | 2020 | 18 | 0.210 |
Why?
|
| Blood Loss, Surgical | 3 | 2024 | 122 | 0.210 |
Why?
|
| Depression | 4 | 2024 | 526 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2024 | 542 | 0.210 |
Why?
|
| Longitudinal Studies | 4 | 2025 | 1117 | 0.210 |
Why?
|
| Vaginal Smears | 2 | 2014 | 70 | 0.210 |
Why?
|
| Muscle, Skeletal | 3 | 2005 | 475 | 0.210 |
Why?
|
| Implantable Neurostimulators | 2 | 2014 | 12 | 0.210 |
Why?
|
| Cholinergic Antagonists | 1 | 2023 | 28 | 0.200 |
Why?
|
| White Matter | 1 | 2024 | 86 | 0.200 |
Why?
|
| Program Evaluation | 3 | 2011 | 316 | 0.200 |
Why?
|
| Pelvic Girdle Pain | 1 | 2022 | 1 | 0.200 |
Why?
|
| Electrodes | 3 | 2011 | 89 | 0.200 |
Why?
|
| Gardnerella | 1 | 2022 | 2 | 0.200 |
Why?
|
| Poverty | 1 | 2024 | 189 | 0.200 |
Why?
|
| Health Behavior | 2 | 2022 | 185 | 0.200 |
Why?
|
| Life Change Events | 1 | 2022 | 48 | 0.190 |
Why?
|
| Low Back Pain | 1 | 2022 | 51 | 0.190 |
Why?
|
| Abdominoplasty | 1 | 2022 | 2 | 0.190 |
Why?
|
| Patient Discharge | 2 | 2022 | 339 | 0.190 |
Why?
|
| Linguistics | 1 | 2021 | 12 | 0.180 |
Why?
|
| Surgical Oncology | 2 | 2020 | 28 | 0.180 |
Why?
|
| Granulation Tissue | 1 | 2021 | 15 | 0.180 |
Why?
|
| Foreign Bodies | 1 | 2002 | 65 | 0.180 |
Why?
|
| Algorithms | 6 | 2019 | 1960 | 0.180 |
Why?
|
| Rectum | 1 | 2002 | 148 | 0.180 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 488 | 0.180 |
Why?
|
| Phenotype | 2 | 2025 | 2503 | 0.180 |
Why?
|
| Remission, Spontaneous | 1 | 2021 | 53 | 0.180 |
Why?
|
| Muscle, Striated | 1 | 2021 | 6 | 0.180 |
Why?
|
| Translations | 1 | 2020 | 5 | 0.170 |
Why?
|
| Urinary Bladder Fistula | 1 | 2020 | 4 | 0.170 |
Why?
|
| Contraceptive Agents | 1 | 2021 | 26 | 0.170 |
Why?
|
| Tobacco Use | 1 | 2021 | 28 | 0.170 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 12 | 0.170 |
Why?
|
| Estradiol | 1 | 2021 | 250 | 0.170 |
Why?
|
| Menorrhagia | 1 | 2021 | 26 | 0.170 |
Why?
|
| Clinical Coding | 1 | 2020 | 24 | 0.170 |
Why?
|
| Estrogens | 1 | 2021 | 200 | 0.170 |
Why?
|
| Primary Health Care | 1 | 2024 | 362 | 0.170 |
Why?
|
| Tolterodine Tartrate | 5 | 2011 | 15 | 0.170 |
Why?
|
| Body Mass Index | 5 | 2018 | 799 | 0.160 |
Why?
|
| Risk Assessment | 7 | 2021 | 2368 | 0.160 |
Why?
|
| Ureteral Obstruction | 1 | 2020 | 69 | 0.160 |
Why?
|
| Stress, Psychological | 3 | 2019 | 329 | 0.160 |
Why?
|
| Vibration | 3 | 2009 | 51 | 0.160 |
Why?
|
| Decision Making | 2 | 2024 | 680 | 0.160 |
Why?
|
| Documentation | 1 | 2020 | 103 | 0.160 |
Why?
|
| Specialties, Surgical | 1 | 2020 | 70 | 0.160 |
Why?
|
| Telemedicine | 1 | 2023 | 213 | 0.160 |
Why?
|
| Cough | 2 | 2012 | 56 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 71 | 0.160 |
Why?
|
| Hot Temperature | 3 | 2009 | 214 | 0.160 |
Why?
|
| Urinary Fistula | 1 | 2019 | 7 | 0.150 |
Why?
|
| Vaginal Fistula | 1 | 2019 | 4 | 0.150 |
Why?
|
| Circumcision, Female | 1 | 2019 | 4 | 0.150 |
Why?
|
| Ureteral Diseases | 1 | 2019 | 14 | 0.150 |
Why?
|
| Body Image | 2 | 2009 | 81 | 0.150 |
Why?
|
| Language | 1 | 2020 | 158 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 128 | 0.150 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 165 | 0.150 |
Why?
|
| Wound Healing | 1 | 2021 | 371 | 0.150 |
Why?
|
| Organization and Administration | 1 | 2018 | 10 | 0.150 |
Why?
|
| Reproductive Medicine | 1 | 2018 | 8 | 0.150 |
Why?
|
| Perinatology | 1 | 2018 | 14 | 0.150 |
Why?
|
| Reference Values | 3 | 2008 | 660 | 0.140 |
Why?
|
| Activities of Daily Living | 2 | 2017 | 211 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2019 | 110 | 0.140 |
Why?
|
| Colposcopy | 3 | 2008 | 16 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 443 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 210 | 0.140 |
Why?
|
| Focus Groups | 3 | 2023 | 186 | 0.140 |
Why?
|
| Personal Satisfaction | 1 | 2018 | 67 | 0.140 |
Why?
|
| Self Report | 1 | 2019 | 307 | 0.140 |
Why?
|
| Colorectal Surgery | 1 | 2018 | 22 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 1075 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 175 | 0.140 |
Why?
|
| Health Status | 2 | 2024 | 375 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2018 | 130 | 0.140 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 267 | 0.140 |
Why?
|
| Rectal Diseases | 2 | 2007 | 23 | 0.130 |
Why?
|
| Ultrasonography | 3 | 2022 | 708 | 0.130 |
Why?
|
| Medicare | 1 | 2020 | 440 | 0.130 |
Why?
|
| Microscopy | 1 | 2017 | 88 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 119 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 225 | 0.130 |
Why?
|
| Weight-Bearing | 1 | 2017 | 69 | 0.130 |
Why?
|
| Physical Therapy Modalities | 2 | 2024 | 86 | 0.130 |
Why?
|
| Treatment Failure | 4 | 2011 | 288 | 0.130 |
Why?
|
| Coitus | 1 | 2016 | 20 | 0.130 |
Why?
|
| Disease Progression | 1 | 2021 | 1500 | 0.130 |
Why?
|
| Perineum | 3 | 2016 | 37 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 808 | 0.120 |
Why?
|
| Predictive Value of Tests | 8 | 2013 | 1761 | 0.120 |
Why?
|
| Stents | 1 | 2019 | 417 | 0.120 |
Why?
|
| Oocyte Retrieval | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cicatrix | 1 | 2016 | 71 | 0.120 |
Why?
|
| Anxiety | 1 | 2018 | 324 | 0.120 |
Why?
|
| Psychometrics | 6 | 2013 | 335 | 0.120 |
Why?
|
| Internet | 1 | 2018 | 331 | 0.120 |
Why?
|
| Qualitative Research | 3 | 2023 | 325 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 329 | 0.120 |
Why?
|
| Urological Agents | 1 | 2015 | 5 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 315 | 0.120 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 37 | 0.110 |
Why?
|
| Anesthesia, General | 1 | 2016 | 119 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 1043 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2023 | 259 | 0.110 |
Why?
|
| Health Surveys | 3 | 2010 | 242 | 0.110 |
Why?
|
| Ergonomics | 1 | 2014 | 23 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 276 | 0.110 |
Why?
|
| Perception | 3 | 2012 | 183 | 0.110 |
Why?
|
| Posture | 1 | 2014 | 123 | 0.110 |
Why?
|
| Illinois | 2 | 2018 | 502 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 807 | 0.110 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2014 | 3 | 0.110 |
Why?
|
| Human Papillomavirus DNA Tests | 1 | 2014 | 2 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2013 | 405 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2015 | 355 | 0.100 |
Why?
|
| Vaginal Diseases | 1 | 2013 | 28 | 0.100 |
Why?
|
| Workload | 1 | 2014 | 130 | 0.100 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2014 | 81 | 0.100 |
Why?
|
| Lactation | 1 | 2013 | 55 | 0.100 |
Why?
|
| Incidence | 4 | 2021 | 1661 | 0.100 |
Why?
|
| Schools | 2 | 2024 | 79 | 0.100 |
Why?
|
| Motor Activity | 2 | 2012 | 330 | 0.100 |
Why?
|
| Urinary Bladder Diseases | 2 | 2003 | 40 | 0.100 |
Why?
|
| Lumbosacral Plexus | 1 | 2012 | 10 | 0.100 |
Why?
|
| Sexuality | 2 | 2010 | 41 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2014 | 165 | 0.100 |
Why?
|
| Habits | 2 | 2022 | 18 | 0.100 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2013 | 34 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2012 | 899 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2008 | 305 | 0.090 |
Why?
|
| Breast Feeding | 1 | 2013 | 106 | 0.090 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2011 | 4 | 0.090 |
Why?
|
| Quinuclidines | 1 | 2011 | 26 | 0.090 |
Why?
|
| Polytetrafluoroethylene | 2 | 2020 | 74 | 0.090 |
Why?
|
| Cosmetic Techniques | 1 | 2011 | 28 | 0.090 |
Why?
|
| Incidental Findings | 1 | 2012 | 98 | 0.090 |
Why?
|
| Action Potentials | 2 | 2012 | 604 | 0.090 |
Why?
|
| Urinalysis | 2 | 2012 | 31 | 0.090 |
Why?
|
| Motion | 1 | 2010 | 94 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 274 | 0.080 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 390 | 0.080 |
Why?
|
| Peer Group | 1 | 2011 | 90 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2011 | 163 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 292 | 0.080 |
Why?
|
| Recurrence | 2 | 2019 | 1180 | 0.080 |
Why?
|
| Appointments and Schedules | 2 | 2023 | 57 | 0.080 |
Why?
|
| Libido | 1 | 2009 | 9 | 0.080 |
Why?
|
| Cystitis | 1 | 2009 | 13 | 0.080 |
Why?
|
| Skin | 2 | 2012 | 595 | 0.080 |
Why?
|
| Obstetrical Forceps | 2 | 2021 | 9 | 0.080 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2009 | 13 | 0.080 |
Why?
|
| Symptom Assessment | 2 | 2019 | 69 | 0.080 |
Why?
|
| Hospitalization | 1 | 2015 | 925 | 0.080 |
Why?
|
| Tissue Transplantation | 1 | 2008 | 12 | 0.080 |
Why?
|
| Hyperalgesia | 1 | 2009 | 22 | 0.070 |
Why?
|
| Overweight | 1 | 2009 | 120 | 0.070 |
Why?
|
| Emotions | 2 | 2023 | 365 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2008 | 161 | 0.070 |
Why?
|
| Pelvic Bones | 1 | 2008 | 45 | 0.070 |
Why?
|
| Office Visits | 2 | 2023 | 49 | 0.070 |
Why?
|
| Biopsy | 1 | 2012 | 1194 | 0.070 |
Why?
|
| Muscle Hypertonia | 1 | 2008 | 17 | 0.070 |
Why?
|
| Organizational Objectives | 1 | 2008 | 24 | 0.070 |
Why?
|
| Odds Ratio | 3 | 2020 | 694 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 658 | 0.070 |
Why?
|
| Perioperative Care | 1 | 2010 | 173 | 0.070 |
Why?
|
| Bacteria | 1 | 2012 | 500 | 0.070 |
Why?
|
| Urethral Diseases | 1 | 2007 | 14 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 172 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 369 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 145 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2008 | 235 | 0.070 |
Why?
|
| Canada | 1 | 2007 | 205 | 0.070 |
Why?
|
| Genital Diseases, Female | 1 | 2007 | 24 | 0.070 |
Why?
|
| Laparotomy | 1 | 2007 | 68 | 0.070 |
Why?
|
| Cost Control | 1 | 2006 | 44 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 31 | 0.070 |
Why?
|
| Anus Diseases | 1 | 2006 | 15 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 346 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 2032 | 0.060 |
Why?
|
| Feedback, Psychological | 1 | 2006 | 19 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 154 | 0.060 |
Why?
|
| Reagent Strips | 1 | 2006 | 4 | 0.060 |
Why?
|
| Colonic Diseases | 1 | 2006 | 61 | 0.060 |
Why?
|
| Competency-Based Education | 1 | 2006 | 38 | 0.060 |
Why?
|
| Nerve Compression Syndromes | 1 | 2006 | 19 | 0.060 |
Why?
|
| Achievement | 1 | 2006 | 29 | 0.060 |
Why?
|
| Neuralgia | 1 | 2006 | 33 | 0.060 |
Why?
|
| Students, Medical | 1 | 2011 | 434 | 0.060 |
Why?
|
| Bacteroides Infections | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cesarean Section, Repeat | 1 | 2005 | 3 | 0.060 |
Why?
|
| Catheterization | 1 | 2007 | 237 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 1785 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2008 | 218 | 0.060 |
Why?
|
| Mentors | 1 | 2006 | 95 | 0.060 |
Why?
|
| Prosthesis-Related Infections | 1 | 2005 | 56 | 0.060 |
Why?
|
| Bacteroides fragilis | 1 | 2005 | 46 | 0.060 |
Why?
|
| Leg | 1 | 2005 | 138 | 0.060 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2024 | 4 | 0.060 |
Why?
|
| Organ Size | 2 | 2021 | 374 | 0.060 |
Why?
|
| Patient Readmission | 2 | 2022 | 391 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 130 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 106 | 0.050 |
Why?
|
| Nuclear Family | 1 | 2024 | 94 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2005 | 203 | 0.050 |
Why?
|
| Solifenacin Succinate | 2 | 2015 | 6 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2005 | 155 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 594 | 0.050 |
Why?
|
| Prescriptions | 1 | 2023 | 26 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 111 | 0.050 |
Why?
|
| Labor, Obstetric | 1 | 2003 | 46 | 0.050 |
Why?
|
| Sacroiliac Joint | 1 | 2022 | 10 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 177 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2013 | 3514 | 0.050 |
Why?
|
| Tissue Adhesions | 1 | 2002 | 52 | 0.050 |
Why?
|
| Diarrhea | 2 | 2018 | 180 | 0.050 |
Why?
|
| Child | 2 | 2024 | 7309 | 0.050 |
Why?
|
| Grooming | 1 | 2021 | 17 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 148 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2021 | 97 | 0.050 |
Why?
|
| Intention to Treat Analysis | 2 | 2012 | 75 | 0.040 |
Why?
|
| Trial of Labor | 1 | 2021 | 5 | 0.040 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2021 | 6 | 0.040 |
Why?
|
| Maternal Age | 1 | 2021 | 46 | 0.040 |
Why?
|
| Administration, Intravesical | 1 | 2021 | 34 | 0.040 |
Why?
|
| Polydioxanone | 1 | 2020 | 4 | 0.040 |
Why?
|
| Anesthesia, Epidural | 1 | 2021 | 32 | 0.040 |
Why?
|
| Fertility | 1 | 2021 | 116 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2020 | 48 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 886 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2021 | 151 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 223 | 0.040 |
Why?
|
| Dilatation and Curettage | 1 | 2019 | 3 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 462 | 0.040 |
Why?
|
| Pyelonephritis | 1 | 2019 | 9 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 675 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 152 | 0.040 |
Why?
|
| Catholicism | 1 | 2019 | 45 | 0.040 |
Why?
|
| Conservative Treatment | 1 | 2019 | 24 | 0.040 |
Why?
|
| Replantation | 1 | 2019 | 36 | 0.040 |
Why?
|
| Orgasm | 1 | 2018 | 9 | 0.040 |
Why?
|
| Ethiopia | 1 | 2018 | 36 | 0.040 |
Why?
|
| Age Distribution | 2 | 2009 | 206 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2018 | 50 | 0.040 |
Why?
|
| Physical Examination | 2 | 2009 | 151 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 270 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2008 | 69 | 0.030 |
Why?
|
| Mental Health | 1 | 2018 | 184 | 0.030 |
Why?
|
| Parity | 2 | 2009 | 97 | 0.030 |
Why?
|
| Esthetics | 1 | 2016 | 49 | 0.030 |
Why?
|
| Probability | 2 | 2009 | 358 | 0.030 |
Why?
|
| Pseudoephedrine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2015 | 11 | 0.030 |
Why?
|
| Imipramine | 1 | 2015 | 16 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 121 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 20 | 0.030 |
Why?
|
| Intention | 1 | 2015 | 52 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 39 | 0.030 |
Why?
|
| Animals | 4 | 2021 | 28059 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 903 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2009 | 0.030 |
Why?
|
| Intervertebral Disc | 1 | 2013 | 26 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2015 | 327 | 0.020 |
Why?
|
| Checklist | 1 | 2013 | 68 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2012 | 78 | 0.020 |
Why?
|
| Rest | 1 | 2012 | 51 | 0.020 |
Why?
|
| Bacteriuria | 1 | 2012 | 9 | 0.020 |
Why?
|
| Molecular Typing | 1 | 2012 | 17 | 0.020 |
Why?
|
| Salpingectomy | 1 | 2011 | 3 | 0.020 |
Why?
|
| Chicago | 1 | 2016 | 1463 | 0.020 |
Why?
|
| Critical Care | 1 | 2015 | 397 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 164 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2011 | 86 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 152 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 109 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 247 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 191 | 0.020 |
Why?
|
| Syndrome | 1 | 2011 | 448 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 763 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2012 | 290 | 0.020 |
Why?
|
| Femininity | 1 | 2009 | 3 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2010 | 55 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 2009 | 35 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2008 | 51 | 0.020 |
Why?
|
| Prolapse | 1 | 2008 | 10 | 0.020 |
Why?
|
| Social Perception | 1 | 2009 | 94 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 26 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 876 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 234 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2008 | 51 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 169 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 986 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 1112 | 0.020 |
Why?
|
| Drainage | 1 | 2009 | 168 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2009 | 304 | 0.020 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2008 | 52 | 0.020 |
Why?
|
| Polysomnography | 1 | 2008 | 152 | 0.020 |
Why?
|
| Cystocele | 1 | 2007 | 7 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 114 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 2006 | 18 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2008 | 800 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 186 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 1150 | 0.010 |
Why?
|
| Device Removal | 1 | 2005 | 165 | 0.010 |
Why?
|
| Hernia | 1 | 2003 | 22 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 215 | 0.010 |
Why?
|
| Labor Stage, First | 1 | 2003 | 3 | 0.010 |
Why?
|
| Labor Stage, Second | 1 | 2003 | 6 | 0.010 |
Why?
|
| Science | 1 | 2004 | 35 | 0.010 |
Why?
|
| California | 1 | 2003 | 156 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2004 | 133 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 198 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2003 | 221 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 379 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 437 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 3872 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2005 | 609 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 2450 | 0.010 |
Why?
|